These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Development of target protein-selective degradation inducer for protein knockdown. Itoh Y; Ishikawa M; Kitaguchi R; Sato S; Naito M; Hashimoto Y Bioorg Med Chem; 2011 May; 19(10):3229-41. PubMed ID: 21515062 [TBL] [Abstract][Full Text] [Related]
24. High throughput chemical library screening identifies a novel p110-δ inhibitor that potentiates the anti-myeloma effect of bortezomib. Malek E; Driscoll JJ Oncotarget; 2016 Jun; 7(25):38523-38538. PubMed ID: 27229530 [TBL] [Abstract][Full Text] [Related]
25. Small molecule inhibitors of disulfide bond formation by the bacterial DsbA-DsbB dual enzyme system. Halili MA; Bachu P; Lindahl F; Bechara C; Mohanty B; Reid RC; Scanlon MJ; Robinson CV; Fairlie DP; Martin JL ACS Chem Biol; 2015 Apr; 10(4):957-64. PubMed ID: 25603425 [TBL] [Abstract][Full Text] [Related]
26. Discovery of an Irreversible and Cell-Active BCL6 Inhibitor Selectively Targeting Cys53 Located at the Protein-Protein Interaction Interface. Sameshima T; Yamamoto T; Sano O; Sogabe S; Igaki S; Sakamoto K; Ida K; Gotou M; Imaeda Y; Sakamoto J; Miyahisa I Biochemistry; 2018 Feb; 57(8):1369-1379. PubMed ID: 29293322 [TBL] [Abstract][Full Text] [Related]
27. SC06, a novel small molecule compound, displays preclinical activity against multiple myeloma by disrupting the mTOR signaling pathway. Han K; Xu X; Xu Z; Chen G; Zeng Y; Zhang Z; Cao B; Kong Y; Tang X; Mao X Sci Rep; 2015 Sep; 5():12809. PubMed ID: 26329846 [TBL] [Abstract][Full Text] [Related]
28. Rational design of resorcylic acid lactone analogues as covalent MNK1/2 kinase inhibitors by tuning the reactivity of an enamide Michael acceptor. Xu J; Chen A; Joy J; Xavier VJ; Ong EH; Hill J; Chai CL ChemMedChem; 2013 Sep; 8(9):1483-94. PubMed ID: 23929665 [TBL] [Abstract][Full Text] [Related]
29. Fragment-based discovery of hydroxy-indazole-carboxamides as novel small molecule inhibitors of Hsp90. Buchstaller HP; Eggenweiler HM; Sirrenberg C; Grädler U; Musil D; Hoppe E; Zimmermann A; Schwartz H; März J; Bomke J; Wegener A; Wolf M Bioorg Med Chem Lett; 2012 Jul; 22(13):4396-403. PubMed ID: 22632933 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, mechanistic and histopathological studies of small-molecules of novel indole-2-carboxamides and pyrazino[1,2-a]indol-1(2H)-ones as potential anticancer agents effecting the reactive oxygen species production. Youssif BGM; Abdelrahman MH; Abdelazeem AH; Abdelgawad MA; Ibrahim HM; Salem OIA; Mohamed MFA; Treambleau L; Bukhari SNA Eur J Med Chem; 2018 Feb; 146():260-273. PubMed ID: 29407956 [TBL] [Abstract][Full Text] [Related]
31. Structure-based design of HSPA5 inhibitors: from peptide to small molecule inhibitors. Huang M; Li Z; Li D; Walker S; Greenan C; Kennedy R Bioorg Med Chem Lett; 2013 May; 23(10):3044-50. PubMed ID: 23562057 [TBL] [Abstract][Full Text] [Related]
32. Protein disulfide isomerase P5-immunopositive inclusions in patients with Alzheimer's disease. Honjo Y; Horibe T; Torisawa A; Ito H; Nakanishi A; Mori H; Komiya T; Takahashi R; Kawakami K J Alzheimers Dis; 2014; 38(3):601-9. PubMed ID: 24037032 [TBL] [Abstract][Full Text] [Related]
33. Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings. Hirai G; Sodeoka M Acc Chem Res; 2015 May; 48(5):1464-73. PubMed ID: 25894598 [TBL] [Abstract][Full Text] [Related]
34. Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening. Resnick E; Bradley A; Gan J; Douangamath A; Krojer T; Sethi R; Geurink PP; Aimon A; Amitai G; Bellini D; Bennett J; Fairhead M; Fedorov O; Gabizon R; Gan J; Guo J; Plotnikov A; Reznik N; Ruda GF; Díaz-Sáez L; Straub VM; Szommer T; Velupillai S; Zaidman D; Zhang Y; Coker AR; Dowson CG; Barr HM; Wang C; Huber KVM; Brennan PE; Ovaa H; von Delft F; London N J Am Chem Soc; 2019 Jun; 141(22):8951-8968. PubMed ID: 31060360 [TBL] [Abstract][Full Text] [Related]
35. Nitroxide 4-hydroxy-2,2',6,6'-tetramethylpiperidine 1-oxyl (Tempol) inhibits the reductase activity of protein disulfide isomerase via covalent binding to the Cys Santos GB; Gonzalez-Perilli L; Mastrogiovanni M; Aicardo A; Cerdeira CD; Trostchansky A; Brigagão MRPL Chem Biol Interact; 2017 Jun; 272():117-124. PubMed ID: 28532685 [TBL] [Abstract][Full Text] [Related]
36. New small molecules targeting apoptosis and cell viability in osteosarcoma. Maugg D; Rothenaigner I; Schorpp K; Potukuchi HK; Korsching E; Baumhoer D; Hadian K; Smida J; Nathrath M PLoS One; 2015; 10(6):e0129058. PubMed ID: 26039064 [TBL] [Abstract][Full Text] [Related]
37. "Inverse Drug Discovery" Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates. Mortenson DE; Brighty GJ; Plate L; Bare G; Chen W; Li S; Wang H; Cravatt BF; Forli S; Powers ET; Sharpless KB; Wilson IA; Kelly JW J Am Chem Soc; 2018 Jan; 140(1):200-210. PubMed ID: 29265822 [TBL] [Abstract][Full Text] [Related]
38. Diverse Redoxome Reactivity Profiles of Carbon Nucleophiles. Gupta V; Yang J; Liebler DC; Carroll KS J Am Chem Soc; 2017 Apr; 139(15):5588-5595. PubMed ID: 28355876 [TBL] [Abstract][Full Text] [Related]
39. Catalysis of protein folding by protein disulfide isomerase and small-molecule mimics. Kersteen EA; Raines RT Antioxid Redox Signal; 2003 Aug; 5(4):413-24. PubMed ID: 13678529 [TBL] [Abstract][Full Text] [Related]
40. Covalent Small Molecules as Enabling Platforms for Drug Discovery. Dalton SE; Campos S Chembiochem; 2020 Apr; 21(8):1080-1100. PubMed ID: 31833626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]